Common Fund programs capitalize on emerging opportunities to catalyze the rate of progress across multiple biomedical fields. Programs are expected to transform the way a broad spectrum of health research is conducted. Initiatives that comprise Common Fund programs are intended to be catalytic in nature by providing limited term investments in strategic areas to stimulate further research through IC-funded mechanisms.
For these reasons, programs are intended to transition out of the Common Fund in 10 years or less as they mature.
For more information on specific former Common Fund programs, please refer to the programs listed below.
Bioinformatics and Computational Biology
Bridging Interventional Development Gaps (BrIDGs)
Building Blocks, Biological Pathways and Networks
Clinical and Translational Science Awards (CTSAs)
Clinical Research Policy Analysis and Coordination (CRPac)
Genotype-Tissue Expression (GTEx)
Healthcare Systems Research (HCS) Collaboratory
Knockout Mouse Phenotyping Program (KOMP2)
Library of Integrated Network-based Cellular Signatures (LINCS)
Molecular Libraries and Imaging
National Electronics Clinical Trials and Research (NECTAR)
New Models of Data Stewardship
NIH Medical Research Scholars Program
PROMIS: Patient-Reported Outcomes Measurement Information System
Protein Capture Reagents Program (PCRP)
Strengthening the Biomedical Research Workforce
Through the American Recovery and Reinvestment Act (ARRA), the Common Fund received approximately $137M to be spent in fiscal years 2009 and 2010. As a result several awards were funded across a range of biomedical research areas.
The American Recovery and Reinvestment Act of 2009 and the NIH Common Fund
This page last reviewed on October 10, 2022